Loading...
Loading...
Application UK00801007314 · Registered
| Application Number | UK00801007314 |
| Status | Registered |
| Owner | Biofrontera Pharma GmbH |
| Filed | 2009-05-27 |
| Registered | 2010-06-14 |
| Renewal Due | 2029-05-27 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. BELIXOS is currently a registered UK trademark, with renewal due on 2029-05-27. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical, veterinary and sanitary preparations; media for bacteriological cultures; bacteriological preparations for medical or veterinary purposes; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical and veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; enzyme preparations for medical and veterinary purposes; ferments for pharmaceutical purposes; vaccines; nutritive substances for microorganisms; pharmaceutical preparations; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; chemical preparations for veterinary purposes; medicines for human purposes; medicines for veterinary purposes; medicines for dental purposes; ointments and gels for the treatment of skin disorders and skin cancers; all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements.
'BELIXOS' is a registered trademark on the UK IPO register, owned by Biofrontera Pharma GmbH. The application (UK00801007314) was filed on 27 May 2009 and registered on 14 June 2010. The registration is set to expire on 27 May 2029.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Lenzing Gerber Stute Partnerschaftsgesellschaft von Patentanwälten.
UK trademark UK00801007314 for the mark 'BELIXOS' in Class 5 is recorded on the UK IPO register as owned by Biofrontera Pharma GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00801007314 for the mark 'BELIXOS' as registered.
UK trademark UK00801007314 for the mark 'BELIXOS' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical, veterinary and sanitary preparations; media for bacteriological cultures; bacteriological preparations for medical or veterinary purposes; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical and veterinary purpos…
UK trademark UK00801007314 for the mark 'BELIXOS' was filed at the UK IPO on 27 May 2009 and registered on 14 June 2010.
UK trademark UK00801007314 for the mark 'BELIXOS' is currently recorded as valid until 27 May 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Lenzing Gerber Stute Partnerschaftsgesellschaft von Patentanwälten is listed as the attorney / representative of record for UK trademark UK00801007314 for the mark 'BELIXOS' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "BELIXOS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| BELIXOSSame applicant | 79080810 | 404 | 2010-02-10 |
| BELIXOSSame applicant | 79070762 | 709 | 2009-05-27 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| BELIXOSSame applicant | 1313519 | protected | 2009-08-06 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.